News + Filings Transactions Holdings
|
|
ORBIMED ADVISORS LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
| Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
|
BAXTER INTERNATIONAL INC
| BAX | Common | 3,375,000 | 1,813,000 | 153,765,000,000 | 90,410,280,000 | 2.79 | |
Hist
| 06/30/2023 |
|
R1 RCM Inc. /DE
| RCM | Common | 3,441,000 | 1,691,000 | 63,486,450,000 | 37,236,450,000 | 1.15 | |
Hist
| 06/30/2023 |
|
Vaxcyte, Inc.
| PCVX | Common | 1,007,148 | 277,709 | 50,296,971,000 | 22,957,597,000 | 0.91 | 1.07 |
Hist
| 06/30/2023 |
|
BIOGEN INC.
| BIIB | Common | 556,800 | 51,800 | 158,604,480,000 | 18,199,330,000 | 2.87 | |
Hist
| 06/30/2023 |
|
Vera Therapeutics, Inc.
| VERA | Common | 1,756,800 | 394,400 | 28,196,640,000 | 17,624,416,000 | 0.51 | |
Hist
| 06/30/2023 |
|
Syndax Pharmaceuticals Inc
| SNDX | Common | 2,530,240 | 818,565 | 52,957,923,000 | 16,807,347,000 | 0.96 | 3.68 |
Hist
| 06/30/2023 |
|
IONIS PHARMACEUTICALS INC
| IONS | Common | 2,169,500 | 45,000 | 89,014,585,000 | 13,084,955,000 | 1.61 | 1.52 |
Hist
| 06/30/2023 |
|
Horizon Therapeutics Public Ltd Co
| HZNP | Common Stock | 316,400 | 116,400 | 32,541,740,000 | 10,713,740,000 | 0.59 | |
Hist
| 06/30/2023 |
|
AMICUS THERAPEUTICS, INC.
| FOLD | COM | 1,856,400 | 685,400 | 23,316,384,000 | 10,329,994,000 | 0.42 | 0.66 |
Hist
| 06/30/2023 |
|
AMGEN INC
| AMGN | Common | 127,300 | 50,600 | 28,263,146,000 | 9,720,921,000 | 0.51 | 0.02 |
Hist
| 06/30/2023 |
|
X4 Pharmaceuticals, Inc
| XFOR | Common | 7,133,515 | 1,315,789 | 13,839,019,000 | 8,777,597,000 | 0.25 | |
Hist
| 06/30/2023 |
|
Immatics N.V.
| IMTX | Common | 966,829 | 19,581 | 11,157,207,000 | 4,621,196,000 | 0.20 | 1.26 |
Hist
| 06/30/2023 |
|
Scholar Rock Holding Corp
| SRRK | Common | 735,645 | 220,645 | 5,546,763,000 | 1,426,763,000 | 0.10 | 1.35 |
Hist
| 06/30/2023 |
|
Passage BIO, Inc.
| PASG | Common | 10,124,576 | 1,192,577 | 9,530,263,000 | 976,088,000 | 0.17 | 18.53 |
Hist
| 06/30/2023 |
|
Revance Therapeutics, Inc.
| RVNC | Common | 100,000 | 50,000 | 2,531,000,000 | 920,500,000 | 0.05 | 0.12 |
Hist
| 06/30/2023 |
|
BiomX Inc.
| | Common | 4,553,489 | 1,392,000 | 1,639,256,000 | 675,002,000 | 0.03 | |
Hist
| 06/30/2023 |
|
Altimmune, Inc.
| ALT | COM NEW | 100,000 | 49,400 | 353,000,000 | 139,468,000 | 0.01 | 0.20 |
Hist
| 06/30/2023 |
|
Mersana Therapeutics, Inc.
| MRSN | Call | 250,000 | 39,300 | 822,500,000 | -43,477,000 | 0.01 | |
Hist
| 06/30/2023 |
|
THERMO FISHER SCIENTIFIC INC.
| TMO | Common | 162,800 | 15,000 | 84,940,900,000 | -246,586,000 | 1.54 | 0.04 |
Hist
| 06/30/2023 |
|
GoodRx Holdings, Inc.
| GDRX | COM CL A | 1,788,600 | 88,600 | 9,873,072,000 | -751,928,000 | 0.18 | |
Hist
| 06/30/2023 |
|
Travere Therapeutics, Inc.
| TVTX | Common | 2,118,100 | 373,800 | 32,534,016,000 | -6,695,291,000 | 0.59 | 3.27 |
Hist
| 06/30/2023 |
|
Kinnate Biopharma Inc.
| KNTE | Common | 8,009,729 | 2,866,100 | 24,269,479,000 | -7,878,202,000 | 0.44 | 17.20 |
Hist
| 06/30/2023 |
|
Prelude Therapeutics Inc
| PRLD | Common | 10,909,256 | 869,565 | 49,091,652,000 | -8,134,587,000 | 0.89 | 22.75 |
Hist
| 06/30/2023 |
|
Enliven Therapeutics, Inc.
| ELVN | Common | 8,998,338 | 2,125 | 183,656,079,000 | -13,360,986,000 | 3.33 | 21.89 |
Hist
| 06/30/2023 |
|
Adicet Bio, Inc.
| ACET | Common | 8,322,140 | 875,000 | 20,222,800,000 | -22,672,726,000 | 0.37 | 19.37 |
Hist
| 06/30/2023 |
|
|
|
|